Inc., USA has launched the Latanoprost Ophthalmic Solution, 0.005% (0.05 mg/mL), a product that is bioequivalent and therapeutically equivalent to the reference listed drug, Xalatan Ophthalmic ...
Purpose: We investigated the intraocular pressure (IOP) variations after switching from 0.005% latanoprost to 0.01% bimatoprost in open-angle glaucoma patients who experienced IOP elevation during ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback